Cancer cell killing by target antigen engagement with engineered complementary intracellular antibody single domains fused to pro-caspase3. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-44908-7
PubMed Identifier: 31189945
Publication URI: http://europepmc.org/abstract/MED/31189945
Type: Journal Article/Review
Volume: 9
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322